IFAN

IFAN Financial Inc (PK)

0.0013
-0.0001 (-7.14%)

Period:

Draw Mode:

Volume 9,910,788
Bid Price 0.001
Ask Price 0.0013
News -
Day High 0.0013

Low
0.000001

52 Week Range

High
0.0024

Day Low 0.0009
Company Name Stock Ticker Symbol Market Type
IFAN Financial Inc (PK) IFAN OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0001 -7.14% 0.0013 17:00:01
Open Price Low Price High Price Close Price Prev Close
0.0013 0.0009 0.0013 0.0013 0.0014
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
74 9,910,788 $ 0.001176 $ 11,658 - 0.000001 - 0.0024
Last Trade Time Type Quantity Stock Price Currency
15:26:08 15,000 $ 0.0013 USD

IFAN Financial Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.58M 1.21B 684.14M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.26M $ - - - -

more financials information »

IFAN Financial (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IFAN Message Board. Create One! See More Posts on IFAN Message Board See More Message Board Posts

Historical IFAN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00070.00150.00050.001009831,090,4370.000685.71%
1 Month0.00020.00150.0000010.000884212,140,5090.0011550.0%
3 Months0.00010.00150.0000010.00075346,203,0930.00121,200.0%
6 Months0.000750.00150.0000010.0005276,653,0050.0005573.33%
1 Year0.001350.00240.0000010.0007494,460,069-0.00005-3.7%
3 Years0.00040.0520.0000010.01202129,899,2230.0009225.0%
5 Years0.00040.0520.0000010.01093836,814,2210.0009225.0%

IFAN Financial (PK) Description

IFAN - Palantir Bioceuticals is a biopharmaceutical company offering holistic solutions to mental health illnesses. Palantir Bioceuticals use a radical innovation called psychedelic-assisted psychotherapy (PAP), supervised use of ketamine, MDMA, psilocybin, LSD, and ibogaine as part of elaborated psychotherapy programs.